In vivo methods of nanotoxicology

Methods in Molecular Biology

Volumn 926, Issue , 2012, Pages 235-253

  Greish, Khaled ^a   Thiagarajan, Giridhar ^b   Ghandehari, Hamidreza ^c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b Department of Electrical and Computer Engineering   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Biocompatibility; In vivo; Nanotechnology; Nanotoxicology; Safety

Indexed keywords

NANOMATERIAL; NANOPARTICLE;

ARTICLE; CARCINOGENICITY; CELL DIVISION; CELL VIABILITY; CLINICAL OBSERVATION; GENOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; MATHEMATICAL MODEL; MITOCHONDRION; MORTALITY; NANOTOXICOLOGY; NEUROTOXICOLOGY; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL; WEIGHT CHANGE;

EID: 84934437569     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-2-1_17     Document Type: Article

References (40)

1. Borm PJ, Kreyling W (2004) Toxicological hazards of inhaled nanoparticles-potential implications for drug delivery. J Nanosci Nanotechnol 4:521-531
2. Oberdorster G, Oberdorster E, Oberdorster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultra fine particles. Environ Health Perspect 113:823-839
3. Roco MC (2006) Nanotechnologys future. Sci Am 295:39
4. Assay cascades-Nanotechnology Characterization Laboratory-Assay Cascades -http://ncl.gove/assay-cascade.asp, 2010
5. Gormley AJ, Ghandehari H (2009) Evaluation of toxicity of nanostructures in biological systems. Wiley, Chichester
6. Kroll A, Pillukat MH, Hahn D, Schnekenburger J (2009) Current in vitro methods in nanoparticle risk assessment: limitations and challenges. Eur J Pharm Biopharm 72:370-377
7. Yang S, Leong KF, Du Z, Chua CK (2001) The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng 7:679-689
8. Holt DJ, Chamberlain LM, Grainger DW (2010) Cell-cell signaling in co-cultures of macrophages and fibroblasts. Biomaterials 31:9382-9394
9. Sayes C, Ivanov I (2010) Comparative study of predictive computational models for nanoparticle-induced cytotoxicity. Risk Anal 30: 1723-1734
10. Derelanko MJ, and Hollinger MA, Handbook of Toxicology, CRC Press, Boca Raton
11. Hodgson E (2004) Introduction to toxicology. Wiley, Hoboken
12. Stine KE, Brown TM (2006) Principles of toxicology, 2nd edn. CRC Press, Boca Raton
13. Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H (2005) Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8
14. Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM (2006) Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci 90:296-303
15. Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM (2008) Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 101:239-253
16. Fiske MJ, Fredenburg RA, VanDerMeid KR, McMichael JC, Arumugham R (2001) Method for reducing endotoxin in Moraxella catarrhalis UspA2 protein preparations. J Chromatogr B Biomed Sci Appl 753:269-278
17. Magalhaes PO, Lopes AM, Mazzola PG, Rangel-Yagui C, Penna TC, Pessoa A Jr (2007) Methods of endotoxin removal from biological preparations: a review. J Pharm Pharm Sci 10:388-404
18. Teeguarden JG, Hinderliter PM, Orr G, Thrall BD, Pounds JG (2007) Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol Sci 95: 300-312
19. Griesh K, Thiagarajan G, Herd H, Price R, Bauer H, Hubbard D, Burckle A, Sadekar S, Yu T, Anwar A, Ray A, Ghandehari H (2010) Size and surface charge signi ficantly in fluence toxicity of silica and dendritic Nanotoxicology. 2011 Jul 28. [Epub ahead of print]
20. Dowell P, Robinson K, Greish K, Ghandehari H, Nan A (2010) In vivo evaluation of the effect of physicochemical properties offunctionalized single-walled carbon nanotubes on acute toxicity and biodistribution (in press)
21. Hudson SP, Padera RF, Langer R, Kohane DS (2008) The biocompatibility of mesoporous silicates. Biomaterials 29:4045-4055
22. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, Stone V, Brown S, Macnee W, Donaldson K (2008) Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 3:423-428
23. Gref R, Luck M, Quellec P, Marchand M, Dellacherie E, Harnisch S, Blunk T, Muller RH (2000) Stealth corona-core nanoparticles surface modi fied by polyethylene glycol (PEG): in fluences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 18: 301-313
24. Balasubramanian SK, Jittiwat J, Manikandan J, Ong CN, Yu LE, Ong WY (2010) Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. Biomaterials 31:2034-2042
25. Leu D, Manthey B, Kreuter J, Speiser P, DeLuca PP (1984) Distribution and elimination of coated polymethyl (2-14C)methacrylate nanoparticles after intravenous injection in rats. J Pharm Sci 73:1433-1437
26. Troster SD, Kreuter J (1992) In fluence of the surface properties of low contact angle surfactants on the body distribution of 14C-poly(methyl methacrylate) nanoparticles. J Microencapsul 9:19-28
27. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R (1994) Biodegradable long-circulating polymeric nanospheres. Science 263:1600-1603
28. Bazile D, Prudhomme C, Bassoullet MT, Marlard M, Spenlehauer G, Veillard M (1995) Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J Pharm Sci 84:493-498
29. Line BR, Mitra A, Nan A, Ghandehari H (2005) Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates. J Nucl Med 46:1552-1560
30. Arnida, Janat-Amsbury MM, Ray A, Peterson CM, Ghandehari H (2011) Geometry and surface characteristics of gold nanoparticles in fluence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm 77:417-423
31. Yang RS, Chang LW, Wu JP, Tsai MH, Wang HJ, Kuo YC, Yeh TK, Yang CS, Lin P (2007) Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment. Environ Health Perspect 115:1339-1343
32. Mortelmans K, Zeiger E (2000) The Ames Salmonella/microsome mutagenicity assay. Mutat Res 455:29-60
33. Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184-191
34. Fenech M (2007) Cytokinesis-block micronucleus cytome assay. Nat Protoc 2:1084-1104
35. Schmid W (1975) The micronucleus test. Mutat Res 31:9-15
36. Sarto F, Finotto S, Giacomelli L, Mazzotti D, Tomanin R, Levis AG (1987) The micronucleus assay in exfoliated cells of the human buccal mucosa. Mutagenesis 2:11-17
37. The International Conference on Harmonisation of Technical Requirement of Registration of Pharmaceuticals for Human Use (ICH)
38. Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22:659-661
39. Saffiotti U, Page NP (1977) Releasing carcinogenesis test results: timing and extent of reporting. Med Pediatr Oncol 3:159-167
40. Lai Y, Chiang P-C, Blom J, Li N, Shevlin K, Brayman T, Hu Y, Selbo J, Hu L (2008) Comparison of in vitro nanoparticles uptake in various cell lines and in vivo pulmonary cellular transport in intratracheally dosed rat model. Nanoscale Res Lett 3:321-329